Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maija Saraste

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Neurological Research|August 23, 2007
CCR7 expression on peripheral blood lymphocytes is up-regulated following treatment of multiple sclerosis with interferon-betaAnna-Maija Vallittu, Maija Saraste, Laura Airas
Neurology(R) Neuroimmunology & Neuroinflammation|November 2, 2016
Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cellsMaija Saraste, Tarja-Leena Penttilä, Laura Airas
Free Neuropathology|July 10, 2025
Multiple sclerosis: 2024 updateLuisa Klotz, Maija Saraste, Laura Airas, et al.
Gender Medicine|June 23, 2007
Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancyMaija Saraste, Saara Väisänen, Anna Alanen, et al.
Journal of Agricultural and Food Chemistry|January 8, 2004
Engineering of a broad specificity antibody for simultaneous detection of 13 sulfonamides at the maximum residue levelTeemu Korpimäki, Eeva-Christine Brockmann, Outi Kuronen, et al.
Multiple Sclerosis and Related Disorders|February 13, 2022
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patientsMaija Saraste, Markus Matilainen, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders|December 22, 2020
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot studyMaija Saraste, Svetlana Bezukladova, Marcus Sucksdorff, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTIMaija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.
Annals of Clinical and Translational Neurology|July 2, 2026
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 2, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosisMaija Saraste, Markus Matilainen, Anna Vuorimaa, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Neurological Research|August 23, 2007
CCR7 expression on peripheral blood lymphocytes is up-regulated following treatment of multiple sclerosis with interferon-betaAnna-Maija Vallittu, Maija Saraste, Laura Airas
Neurology(R) Neuroimmunology & Neuroinflammation|November 2, 2016
Natalizumab treatment leads to an increase in circulating CXCR3-expressing B cellsMaija Saraste, Tarja-Leena Penttilä, Laura Airas
Free Neuropathology|July 10, 2025
Multiple sclerosis: 2024 updateLuisa Klotz, Maija Saraste, Laura Airas, et al.
Gender Medicine|June 23, 2007
Clinical and immunologic evaluation of women with multiple sclerosis during and after pregnancyMaija Saraste, Saara Väisänen, Anna Alanen, et al.
Journal of Agricultural and Food Chemistry|January 8, 2004
Engineering of a broad specificity antibody for simultaneous detection of 13 sulfonamides at the maximum residue levelTeemu Korpimäki, Eeva-Christine Brockmann, Outi Kuronen, et al.
Multiple Sclerosis and Related Disorders|February 13, 2022
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patientsMaija Saraste, Markus Matilainen, Cecilia Rajda, et al.
Multiple Sclerosis and Related Disorders|December 22, 2020
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot studyMaija Saraste, Svetlana Bezukladova, Marcus Sucksdorff, et al.
Multiple Sclerosis and Related Disorders|February 8, 2021
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTIMaija Saraste, Svetlana Bezukladova, Markus Matilainen, et al.
Annals of Clinical and Translational Neurology|July 2, 2026
Baseline Neuroinflammation Stratifies TSPO-PET Response to Disease-Modifying Therapy in Multiple SclerosisMarlene T Morch, Markus Matilainen, Giulia N Baldrighi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 2, 2023
Association of serum neurofilament light with microglial activation in multiple sclerosisMaija Saraste, Markus Matilainen, Anna Vuorimaa, et al.
Pageof 2